Potential therapeutic approaches for Angelman syndrome.

about

mTORC1-S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice How Can a Ketogenic Diet Improve Motor Function?

P2860

Q41378038-7A54C1EC-83FA-4B10-B14C-5F66D8F4AAC2 Q49620553-DD512724-E464-4A31-B8CA-7A4E489FD16C

P2860

Potential therapeutic approaches for Angelman syndrome.

Item

http://www.wikidata.org/entity/Q36992786

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Potential therapeutic approaches for Angelman syndrome.

@en

type

Item

label

Potential therapeutic approaches for Angelman syndrome.

@en

prefLabel

Potential therapeutic approaches for Angelman syndrome.

@en

P1476

Potential therapeutic approaches for Angelman syndrome.

@en

P2093

Angela X Ji

http://www.w3.org/2001/XMLSchema#string

Jiandong Sun

http://www.w3.org/2001/XMLSchema#string

Michel Baudry

http://www.w3.org/2001/XMLSchema#string

Xiaoning Bi

http://www.w3.org/2001/XMLSchema#string

P2860

Minocycline: therapeutic potential in psychiatry

LTP and LTD

Human Na(+)/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria

EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

UBE3A/E6-AP mutations cause Angelman syndrome

SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1

Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

P304

601-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2016.1115837

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26558806

http://www.w3.org/2001/XMLSchema#string

P932

4902328

http://www.w3.org/2001/XMLSchema#string

Potential therapeutic approaches for Angelman syndrome.

about

P2860

P2860

Potential therapeutic approaches for Angelman syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932